Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about psilocybin therapy
Recent news which mentions psilocybin therapy
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
August 14, 2024
Tickers
KAYS
NEWS
Tags
psilocybin therapy
Psychedelics
Craig Frank
From
Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers
NEWS
NUMIF
Tags
Legal
Psychedelics Research
MDMA Therapy
From
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
CYBN
CMPS
Psychedelics Research
From
Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
February 14, 2024
Tickers
NEWS
Tags
Market News
Cannabis
Benzinga
From
Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
March 31, 2023
Tags
Benzinga
Psilocybin Microdosing
Markets
From
Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers
RVVTF
Tags
News
Markets
RVVTF
From
Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
February 15, 2023
Tickers
TRUFF
Tags
TheraPsil
Guidance
TRUFF
From
Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
Tags
News
Management
Legal
From
Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
January 20, 2023
Tags
Benzinga
Cannabis
Markets
From
Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
January 09, 2023
Tags
Missouri
News
Legal
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
Psychedelics
AWKNF
CMND
From
Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
December 28, 2022
Tags
Markets
Cannabis
Market News
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Cannabis
Health Canada Approval
Market News
From
Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags
Health Canada Special Access Program
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
December 12, 2022
Tags
News
psilocybin therapy
Psychedelics
From
Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
December 12, 2022
Tickers
CMPS
Tags
Markets
CMPS
News
From
Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers
CSA
DEA
Tags
Market News
Cannabis
Benzinga
From
Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
October 07, 2022
Tags
Market News
Markets
Cannabis
From
Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
September 30, 2022
Tags
Benzinga
Market News
Breast Cancer Therapy
From
Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
September 22, 2022
Tickers
CMPS
Tags
Market News
Markets
Cannabis
From
Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
September 19, 2022
Tags
Prof/ David Nutt
psilocybin therapy
Psychedelics
From
Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
September 16, 2022
Tickers
RVVTF
Tags
Cannabis
Market News
Dr/ Paul Hutson
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
psilocybin therapy
Psychedelics
major depressive disorder
From
Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 2022
Tickers
AWKNF
RVLWF
Tags
military veterans
News
Management
From
Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
September 06, 2022
Tickers
ATAI
Tags
Cannabis
Market News
Psychedelics Investing
From
Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags
contributors
Benzinga
Market News
From
Benzinga
The Case For Psilocybin Therapy And Depression
January 30, 2022
Tags
contributors
Benzinga
Market News
From
Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
January 27, 2022
Tickers
ATAI
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
December 13, 2021
Tickers
CMPS
Tags
Market News
Guy Goodwin
Markets
From
Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers
ATAI
CMPS
Tags
Markets
David Bronner
Regulations
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.